| abstract |
The present disclosure relates to compounds that are sodium channel inhibitors and the use of these compounds in the treatment of various disease states including cardiovascular disease and diabetes. In certain embodiments, the structures of these compounds are of formula I: I In Formula I, R 1 , R 2 , R 3 , R 4 , and R 5 are as described herein. The present disclosure also relates to methods for preparing and using these compounds, and pharmaceutical compositions containing these compounds. |